In chronic
wounds,
hypoxia seriously undermines tissue repair processes by altering the balances between pro-angiogenic
proteolytic enzymes (
matrix metalloproteinases,
MMPs) and their inhibitors (tissue inhibitors of
metalloproteinases, TIMPs) released from surrounding cells. Recently, we have shown that in human monocytes
hypoxia reduces MMP-9 and increases
TIMP-1 without affecting
TIMP-2 secretion, whereas in human keratinocytes it reduces MMP-2, MMP-9, and
TIMP-2, without affecting
TIMP-1 release. Provided that the phenotype of the cellular environment is better understood, chronic
wounds might be targeted by new oxygenating compounds such as
chitosan- or
dextran-shelled and 2H,3H-decafluoropentane-cored
oxygen-loaded nanodroplets (OLNs). Here, we investigated the effects of
hypoxia and
dextran-shelled OLNs on the pro-angiogenic phenotype and behavior of human dermal microvascular endothelium (HMEC-1 cell line), another cell population playing key roles during wound healing. Normoxic HMEC-1 constitutively released MMP-2,
TIMP-1 and
TIMP-2 proteins, but not MMP-9.
Hypoxia enhanced MMP-2 and reduced
TIMP-1 secretion, without affecting
TIMP-2 levels, and compromised cell ability to migrate and invade the extracellular matrix. When taken up by HMEC-1, nontoxic OLNs abrogated the effects of
hypoxia, restoring normoxic
MMP/TIMP levels and promoting cell migration, matrix invasion, and formation of microvessels. These effects were specifically dependent on time-sustained
oxygen diffusion from OLN core, since they were not achieved by
oxygen-free nanodroplets or
oxygen-saturated
solution. Collectively, these data provide new information on the effects of
hypoxia on dermal endothelium and support the hypothesis that OLNs might be used as effective adjuvant tools to promote chronic wound healing processes.